These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 9166207)

  • 21. Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.
    Kelekci S; Kelekci KH; Yilmaz B
    Contraception; 2012 Nov; 86(5):458-63. PubMed ID: 22832203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of menorrhagia with an LNG-IUS.
    Pakarinen P; Luukkainen T
    Contraception; 2007 Jun; 75(6 Suppl):S118-22. PubMed ID: 17531601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomised comparative trial of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia.
    Shaw RW; Symonds IM; Tamizian O; Chaplain J; Mukhopadhyay S
    Aust N Z J Obstet Gynaecol; 2007 Aug; 47(4):335-40. PubMed ID: 17627692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders.
    Kingman CE; Kadir RA; Lee CA; Economides DL
    BJOG; 2004 Dec; 111(12):1425-8. PubMed ID: 15663130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study.
    Luukkainen T; Allonen H; Haukkamaa M; Holma P; Pyörälä T; Terho J; Toivonen J; Batar I; Lampe L; Andersson K
    Contraception; 1987 Aug; 36(2):169-79. PubMed ID: 3123132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Canadian, multicentre study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia.
    Endrikat J; Shapiro H; Lukkari-Lax E; Kunz M; Schmidt W; Fortier M
    J Obstet Gynaecol Can; 2009 Apr; 31(4):340-347. PubMed ID: 19497153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
    Sturridge F; Guillebaud J
    Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of action of the levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding.
    Cihangir U; Ebru A; Murat E; Levent Y
    Int J Gynaecol Obstet; 2013 Nov; 123(2):146-9. PubMed ID: 24028852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
    Pakarinen PI; Suvisaari J; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of the levonorgestrel-releasing intrauterine system, quality of life and sexuality. Experience in an Italian family planning center.
    Bastianelli C; Farris M; Benagiano G
    Contraception; 2011 Oct; 84(4):402-8. PubMed ID: 21920196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.
    Busfield RA; Farquhar CM; Sowter MC; Lethaby A; Sprecher M; Yu Y; Sadler LC; Brown P; Johnson N
    BJOG; 2006 Mar; 113(3):257-63. PubMed ID: 16487195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two Years Follow-Up of Patients with Abnormal Uterine Bleeding after Insertion of the Levonorgestrel-Releasing Intrauterine System.
    Cim N; Soysal S; Sayan S; Yildizhan B; Karaman E; Cetin O; Tolunay HE; Yildizhan R
    Gynecol Obstet Invest; 2018; 83(6):569-575. PubMed ID: 29223999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of a levonorgestrel 52-mg intrauterine system in the control of abnormal uterine bleeding in women with inherited bleeding disorders.
    Campos RR; Baêta T; Silva-Filho A; Rezende SM; Rocha ALL
    Contraception; 2020 Oct; 102(4):254-258. PubMed ID: 32470465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levonorgestrel-releasing intrauterine device is an efficacious contraceptive for women with leiomyoma.
    Xie ZW; Zhang YN; Wan S; Xu WZ; Chen J
    J Int Med Res; 2012; 40(5):1966-72. PubMed ID: 23206480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Menstrual blood loss in women using the frameless FibroPlant LNG-IUS.
    Andrade A; Wildemeersch D
    Contraception; 2009 Feb; 79(2):134-8. PubMed ID: 19135571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of the levonorgestrel-releasing intrauterine system in perimenopausal women with menorrhagia or dysmenorrhea.
    Yoo HJ; Lee MA; Ko YB; Yang JB; Kang BH; Lee KH
    Arch Gynecol Obstet; 2012 Jan; 285(1):161-6. PubMed ID: 21671063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of menstrual blood loss in women with ideopathic menorrhagia using the frameless levonorgestrel-releasing intrauterine system.
    Wildemeersch D; Rowe PJ
    Contraception; 2004 Aug; 70(2):165-8. PubMed ID: 15288223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levonorgestrel-releasing intrauterine system for heavy menstrual bleeding improves hemoglobin and ferritin levels.
    Kaunitz AM; Bissonnette F; Monteiro I; Lukkari-Lax E; DeSanctis Y; Jensen J
    Contraception; 2012 Nov; 86(5):452-7. PubMed ID: 22959906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.